Company / Shares Outstanding
MoonLake Immunotherapeutics Shares Outstanding History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Shares Outstanding
64.5M
FY2025
5-year range
7.8M / 64.5M
FY2021-FY2025
Trend
+2.5%
vs FY2024
Sector context
#135 of 212
Health Care
What the data says
At 64463889.00, MoonLake Immunotherapeutics's shares outstanding ranks #78 of 212 in the Health Care sector. Shares Outstanding has increased for 5 consecutive years, from 6232090.00 in FY2020 to 64463889.00 in FY2025.
Based on SEC 10-K filings.
64463889.00 in FY2025 with a 5-year CAGR of +59.6%.
Increased from 49122534.00 to 64463889.00 over the past 2 years.
Health Care sector context is included.
Shares Outstanding over time
Growth rates
- 3-Year CAGR
- +30.0%
- 5-Year CAGR
- +59.6%
- 10-Year CAGR
- -
Sector benchmark
#78 of 212 in Health CareTop 36% of 212This company 64.5M Sector average 306.7M
▼
-79.0% below sector average
Key checks
Key Insights
- MoonLake Immunotherapeutics's shares outstanding has grown for 5 consecutive years.
- In FY2025, shares outstanding increased 2.5% year-over-year.
- Ranks #135 out of 212 companies in the Health Care sector.
- Lowest shares outstanding in the period was in FY2020.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -0.09 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Shares OutstandingValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | 64.5M | +2.5% |
| FY2024 | 62.9M | +28.0% |
| FY2023 | 49.1M | +67.3% |
| FY2022 | 29.4M | +274.5% |
| FY2021 | 7.8M | +25.8% |
| FY2020 | 6.2M | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026